You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Neos Theraps Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for NEOS THERAPS, and what generic alternatives to NEOS THERAPS drugs are available?

NEOS THERAPS has four approved drugs.

There are seven US patents protecting NEOS THERAPS drugs.

There are seven patent family members on NEOS THERAPS drugs in five countries.

Summary for Neos Theraps

International Patents:	7
US Patents:	7
Tradenames:	4
Ingredients:	3
NDAs:	4

Drugs and US Patents for Neos Theraps

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Neos Theraps	ADZENYS XR-ODT	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	204326-005	Jan 27, 2016		RX	Yes	No	8,840,924	⤷ Try a Trial	Y			⤷ Try a Trial
Neos Theraps	ADZENYS XR-ODT	amphetamine	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	204326-004	Jan 27, 2016		RX	Yes	No	9,017,731	⤷ Try a Trial	Y			⤷ Try a Trial
Neos Theraps Inc	ADZENYS ER	amphetamine	SUSPENSION, EXTENDED RELEASE;ORAL	204325-001	Sep 15, 2017		DISCN	Yes	No	9,017,731	⤷ Try a Trial	Y			⤷ Try a Trial
Neos Theraps Inc	COTEMPLA XR-ODT	methylphenidate	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	205489-002	Jun 19, 2017		RX	Yes	No	11,166,947	⤷ Try a Trial				⤷ Try a Trial
Neos Theraps Inc	COTEMPLA XR-ODT	methylphenidate	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	205489-002	Jun 19, 2017		RX	Yes	No	9,089,496	⤷ Try a Trial	Y			⤷ Try a Trial
Neos Theraps Inc	HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX	chlorpheniramine polistirex; hydrocodone polistirex	SUSPENSION, EXTENDED RELEASE;ORAL	091671-001	Jun 29, 2012		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Neos Theraps Inc	COTEMPLA XR-ODT	methylphenidate	TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL	205489-002	Jun 19, 2017		RX	Yes	No	9,072,680	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Neos Theraps Drugs

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Japan	2020504763	⤷ Try a Trial
European Patent Office	2726066	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2018085256	⤷ Try a Trial
Australia	2017353921	⤷ Try a Trial
World Intellectual Property Organization (WIPO)	2013003622	⤷ Try a Trial
South Korea	20190107655	⤷ Try a Trial
European Patent Office	3585439	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.